Damage to the spinal cord rarely heals because the
injured nerve cells fail to regenerate. The regrowth of their long nerve fibers
is hindered by scar tissue and molecular processes inside the nerves. An
international team of researchers led by DZNE scientists in Bonn now reports in Science that help might
be on the way from an unexpected quarter: in animal studies, the cancer drug
epothilone reduced the formation of scar tissue in injuries to the spinal cord
and stimulated growth in damaged nerve cells. Both promoted neuronal
regeneration and improved the animals' motor skills.
Nerve cells are wire-like
conductors that transmit and receive signals in the form of electrical
impulses. This function can be impaired by accidents or disease. Whether or not
the affected nerves can recover largely depends on their location: for instance
nerve cells in the limbs, torso and nose can regenerate to some degree and
regain some or all of their function.
In contrast, the neurons
in the brain and spinal cord do not have this ability. If they are damaged by
accident or disease, the patient is likely to suffer long-term paralysis or
other disabilities. But why is regeneration of these neurons and their long
nerve fibers impeded? It is already known that inhibiting factors in newly
formed scar tissue and other cellular processes block axon regrowth.
Figure:
Cross section of Spinal Cord
|
Seeking the ideal
treatment
"The ideal treatment
for promoting axon regeneration after spinal cord injury would inhibit the
formation of scar tissue," says Professor Frank Bradke, who leads a
working group at the DZNE's site in Bonn and who conducted the study.
"However, it is also important that the growth-inhibiting factors are
neutralized while reactivating the poor axons' regenerative potential." A
feasible administration of a potential treatment is also essential for clinical
application.
In cooperation with
international researchers, Bradke and his team have now managed to take another
step towards the development of a future treatment. From their previous
research, it was already known that stabilizing microtubules would reduce the
formation of scar tissue and promote axonal growth. Microtubules are long,
tubular filaments inside the cell that can grow and shrink dynamically. They
are part of the cell's supportive skeleton, which also controls cell growth and
movement.
The substance epothilone
can stabilize microtubules and is already licensed on the American market -- as
a cancer treatment. "It all depends on the dose," says Dr. Jörg
Ruschel, the study's lead author. "In higher doses, epothilone inhibits
the growth of cancer cells, while low doses have been shown to stimulate axonal
growth in animals without the severe side-effects of cancer treatment."
Epothilone is superior to other cancer drugs with a similar effect because it
can penetrate the blood-brain barrier into the central nervous system, thus
reaching the damaged axons directly.
One substance --
many effects
Experiments have shown
epothilone works on several levels. Epothilone reduces the growth of scar
tissue by inhibiting the formation of microtubules in the cells that form the
scar tissue. Therefore they cannot migrate to the spinal cord lesion and cause
wound scarring. At the same time, epothilone promotes growth and regeneration
in the nerve cells by causing microtubules to grow into the damaged axon tips.
Posted BY:-
Bioinformatics Department